Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Lancet [Lancet] NLMUID: 2985213R"" wg kryterium: JN


Tytuł:
Screening mammography at 40-49 years: regret or no regret?
Autorzy:
Djulbegovic B; H Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Department of Interdisciplinary Oncology, Tampa, FL 33612, USA. />Lyman GH
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 Dec 09; Vol. 368 (9552), pp. 2035-7.
Typ publikacji:
Comment; Journal Article
MeSH Terms:
Breast Neoplasms/*diagnosis
Mammography/*adverse effects
Mass Screening/*adverse effects
Adult ; Age Factors ; Breast Neoplasms/mortality ; Breast Neoplasms/prevention & control ; Decision Making ; Female ; Humans ; Mammography/economics ; Mass Screening/economics ; Middle Aged ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.
Autorzy:
Moss SM; Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, UK. />Cuckle H
Evans A
Johns L
Waller M
Bobrow L
Pokaż więcej
Corporate Authors:
Trial Management Group
Źródło:
Lancet (London, England) [Lancet] 2006 Dec 09; Vol. 368 (9552), pp. 2053-60.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/diagnosis
Breast Neoplasms*/mortality
Mammography/*statistics & numerical data
Adult ; Age Factors ; Female ; Follow-Up Studies ; Humans ; Mammography/economics ; Middle Aged ; United Kingdom
Czasopismo naukowe
Tytuł:
A case of breast carcinoma, chemotherapy, and acute appendicitis.
Autorzy:
Hsu SD; Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Chou SJ
Hsieh HF
Yu JC
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 Sep 16; Vol. 368 (9540), pp. 1038.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Antineoplastic Agents/*adverse effects
Appendicitis/*etiology
Breast Neoplasms/*therapy
Carcinoma, Ductal, Breast/*therapy
Antineoplastic Agents/therapeutic use ; Appendicitis/surgery ; Female ; Humans ; Mastectomy, Modified Radical ; Middle Aged
Czasopismo naukowe
Tytuł:
Bradford NHS trust and Panorama.
Autorzy:
Coleman MP
Rachet B
Quaresma M
Lepage C
Baum M
Sikora K
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 Aug 26; Vol. 368 (9537), pp. 730-1; author reply 731-2.
Typ publikacji:
Letter; Comment
MeSH Terms:
Data Interpretation, Statistical*
Public Relations*
Breast Neoplasms/*radiotherapy
Breast Neoplasms/mortality ; Breast Neoplasms/surgery ; Female ; Humans ; Referral and Consultation ; United Kingdom
Opinia redakcyjna
Tytuł:
Effects of radiotherapy and surgery for early breast cancer.
Autorzy:
Promish D
Tai P
Royce M
Vlastos G
Storme G
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 May 20; Vol. 367 (9523), pp. 1652; author reply 1654-5.
Typ publikacji:
Comment; Letter
MeSH Terms:
Breast Neoplasms/*surgery
Neoplasm Recurrence, Local/*mortality
Breast Neoplasms/mortality ; Breast Neoplasms/radiotherapy ; Female ; Humans ; Survival Analysis
Opinia redakcyjna
Tytuł:
Effects of radiotherapy and surgery for early breast cancer.
Autorzy:
Kunkler IH
Williams L
Prescott R
King C
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 May 20; Vol. 367 (9523), pp. 1653-4; author reply 1654-5.
Typ publikacji:
Comment; Letter
MeSH Terms:
Survival Analysis*
Breast Neoplasms/*surgery
Aged ; Breast Neoplasms/mortality ; Breast Neoplasms/radiotherapy ; Female ; Humans ; Postoperative Period ; Time Factors
Opinia redakcyjna
Tytuł:
Effects of radiotherapy and surgery for early breast cancer.
Autorzy:
Cserni G
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 May 20; Vol. 367 (9523), pp. 1652-3; author reply 1654-5.
Typ publikacji:
Comment; Letter
MeSH Terms:
Breast Neoplasms/*surgery
Breast Neoplasms/classification ; Breast Neoplasms/mortality ; Combined Modality Therapy ; Female ; Humans ; Randomized Controlled Trials as Topic
Opinia redakcyjna
Tytuł:
Effects of radiotherapy and surgery for early breast cancer.
Autorzy:
Verschraegen C
Vinh-Hung V
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 May 20; Vol. 367 (9523), pp. 1654; author reply 1654-5.
Typ publikacji:
Comment; Letter
MeSH Terms:
Breast Neoplasms/*radiotherapy
Neoplasm Recurrence, Local/*mortality
Breast Neoplasms/mortality ; Breast Neoplasms/surgery ; Female ; Humans ; Radiotherapy/adverse effects
Opinia redakcyjna
Tytuł:
Chemoprevention of breast cancer.
Autorzy:
O'Regan RM; Winship Cancer Institute, Emory University, Atlanta, GA30322, USA. Ruth_
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 Apr 29; Vol. 367 (9520), pp. 1382-3.
Typ publikacji:
Journal Article
MeSH Terms:
Aromatase Inhibitors/*therapeutic use
Breast Neoplasms/*prevention & control
Raloxifene Hydrochloride/*therapeutic use
Selective Estrogen Receptor Modulators/*therapeutic use
Tamoxifen/*therapeutic use
Clinical Trials as Topic ; Female ; Humans ; Middle Aged
Czasopismo naukowe
Tytuł:
Trial by media: dangers of misinterpretation of medical statistics.
Autorzy:
Wright J; Bradford Hospitals NHS Trust, Bradford BD9 6RJ, UK. />Bradley C
Sheldon T
Lilford R
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 Apr 08; Vol. 367 (9517), pp. 1139-40.
Typ publikacji:
Letter
MeSH Terms:
Public Relations*
Television*
Breast Neoplasms/*surgery
Breast Neoplasms/mortality ; Breast Neoplasms/radiotherapy ; Data Interpretation, Statistical ; Female ; Humans ; Referral and Consultation ; United Kingdom
Opinia redakcyjna
Tytuł:
Trastuzumab for early breast cancer.
Autorzy:
Smith IE
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 Jan 14; Vol. 367 (9505), pp. 107.
Typ publikacji:
Letter; Comment
MeSH Terms:
Attitude of Health Personnel*
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Agents/*therapeutic use
Breast Neoplasms/*drug therapy
Antibodies, Monoclonal, Humanized ; Disease-Free Survival ; Female ; Humans ; Trastuzumab ; United Kingdom
Opinia redakcyjna
Tytuł:
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.
Autorzy:
Clarke M; Clinical Trial Service Unit, Oxford, UK.
Collins R
Darby S
Davies C
Elphinstone P
Evans V
Godwin J
Gray R
Hicks C
James S
MacKinnon E
McGale P
McHugh T
Peto R
Taylor C
Wang Y
Pokaż więcej
Corporate Authors:
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Źródło:
Lancet (London, England) [Lancet] 2005 Dec 17; Vol. 366 (9503), pp. 2087-106.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Breast Neoplasms*/mortality
Breast Neoplasms*/radiotherapy
Breast Neoplasms*/surgery
Aged ; Cause of Death ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/epidemiology ; Probability ; Randomized Controlled Trials as Topic ; Time Factors
Czasopismo naukowe
Tytuł:
Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial.
Autorzy:
Nitz UA; Breast Centre, University Hospital Düsseldorf, Düsseldorf, Germany. />Mohrmann S
Fischer J
Lindemann W
Berdel WE
Jackisch C
Werner C
Ziske C
Kirchner H
Metzner B
Souchon R
Ruffert U
Schütt G
Pollmanns A
Schmoll HJ
Middecke C
Baltzer J
Schrader I
Wiebringhaus H
Ko Y
Rösel S
Schwenzer T
Wernet P
Hinke A
Bender HG
Frick M
Pokaż więcej
Corporate Authors:
West German Study Group
Źródło:
Lancet (London, England) [Lancet] 2005 Dec 03; Vol. 366 (9501), pp. 1935-44.
Typ publikacji:
Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/mortality
Breast Neoplasms*/therapy
Disease-Free Survival*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Peripheral Blood Stem Cell Transplantation/*methods
Adult ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemotherapy, Adjuvant ; Combined Modality Therapy ; Cross-Over Studies ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Middle Aged
Czasopismo naukowe
Tytuł:
Breast cancer.
Autorzy:
Ronckers CM
Land CE
Neglia JP
Meadows AT
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2005 Nov 05; Vol. 366 (9497), pp. 1605-6; author reply 1606.
Typ publikacji:
Comment; Letter
MeSH Terms:
Breast Neoplasms/*etiology
Neoplasms, Radiation-Induced/*epidemiology
Adolescent ; Adult ; Age Factors ; Child ; Child, Preschool ; Female ; Humans ; Incidence ; Infant ; Japan/epidemiology ; Risk
Opinia redakcyjna
Tytuł:
Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study.
Autorzy:
Johnson N; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.
Fletcher O
Naceur-Lombardelli C
dos Santos Silva I
Ashworth A
Peto J
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2005 Oct 29-Nov 4; Vol. 366 (9496), pp. 1554-7.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Breast Neoplasms/*genetics
DNA, Neoplasm/*isolation & purification
Prostatic Neoplasms/*genetics
Protein Serine-Threonine Kinases/*genetics
Adult ; Breast Neoplasms/epidemiology ; Breast Neoplasms/mortality ; Checkpoint Kinase 2 ; DNA, Neoplasm/genetics ; Female ; Heterozygote ; Humans ; Male ; Prevalence ; Prostatic Neoplasms/epidemiology ; Prostatic Neoplasms/mortality ; Protein Serine-Threonine Kinases/isolation & purification ; Registries ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł:
Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.
Autorzy:
Colleoni M; European Institute of Oncology, Milan, Italy. />Li S
Gelber RD
Price KN
Coates AS
Castiglione-Gertsch M
Goldhirsch A
Pokaż więcej
Corporate Authors:
International Breast Cancer Study Group
Źródło:
Lancet (London, England) [Lancet] 2005 Sep 24-30; Vol. 366 (9491), pp. 1108-10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Body Mass Index*
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Breast Neoplasms/*drug therapy
Receptors, Estrogen/*analysis
Breast Neoplasms/complications ; Breast Neoplasms/metabolism ; Breast Neoplasms/mortality ; Chemotherapy, Adjuvant ; Cyclophosphamide/administration & dosage ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Female ; Fluorouracil/administration & dosage ; Humans ; Methotrexate/administration & dosage ; Obesity/complications ; Premenopause ; Randomized Controlled Trials as Topic ; Survival Rate
SCR Protocol:
CMF regimen
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies